Virtual Testis Cancer Lay Support and Survivorship Aim 2
NCT ID: NCT06702592
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
360 participants
INTERVENTIONAL
2026-01-31
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
NCT07173205
Effectiveness of Central Oncology Navigation and the Use of an ORN
NCT06618274
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
NCT05836688
A Biobehavioral Intervention for Young Men With Testicular Cancer
NCT04150848
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
NCT07228637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual support
Participants will have access to the virtual support platform.
Virtual support
Subjects will use a virtual support platform that was built for their needs.
Patient educational material
Participants will have access to patient educational material only.
Patient educational material
Participants will have access to patient educational material.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual support
Subjects will use a virtual support platform that was built for their needs.
Patient educational material
Participants will have access to patient educational material.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is willing and able to comply with study procedures based on the judgment of the investigator.
* Adults aged 18-95 years old.
* Electronic informed consent was obtained to participate in the study.
Exclusion Criteria
* Non-English speaking
* Unwilling or unable to complete informed consent.
* On active treatment for another cancer.
* Actively receiving chemotherapy, radiation, or surgery for testicular cancer.
18 Years
95 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hung-Jui Tan, MD
Role: PRINCIPAL_INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical trials at UNC Lineberger
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCCC2418 AIM2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.